Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery

Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

(2014) M. Hoenigl et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Automation of serum (1->3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia

(2014) F. Pruller et al.   MEDICAL MYCOLOGY

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

(2013) Martin Hoenigl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany

(2013) Oliver Bader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

(1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections

(2013) M. Mikulska et al.   CLINICAL INFECTIOUS DISEASES

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

(2013) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Comparison of (1->3)- -D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia

(2013) J. Held et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pre-emptive treatment of fungal infection based on plasma β-D-glucan levels after gastric surgery for gastric cancer in elderly patients

(2013) Tsutomu Namikawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Inflammatory Monocytes Mediate Early and Organ-Specific Innate Defense During Systemic Candidiasis

(2013) Lisa Y. Ngo et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of micafungin in invasive candidiasis caused by commonCandidaspecies with special emphasis on non-albicans Candidaspecies

(2013) Oliver A. Cornely et al.   MYCOSES

Systemic antifungal therapy in critically ill patients without invasive fungal infection*

(2012) Elie Azoulay et al.   CRITICAL CARE MEDICINE

Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis

(2012) Charles R. Sims et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

(2012) Martin Hoenigl et al.   JOURNAL OF INFECTION

Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies

(2012) Martin Hoenigl et al.   MEDICAL MYCOLOGY

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

(2011) O Marchetti et al.   BONE MARROW TRANSPLANTATION

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

(2011) Valerio Del Bono et al.   Clinical and Vaccine Immunology

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

(2011) Akira Onishi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serum β- d -glucan of critically ill patients with suspected ventilator-associated pneumonia: Preliminary observations

(2011) Daren Heyland et al.   JOURNAL OF CRITICAL CARE

Prospective Survey of (1->3)- -D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

(2010) J. F. Mohr et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies

(2010) M. Hoenigl et al.   MYCOSES

Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases

(2009) Johan Maertens et al.   CLINICAL INFECTIOUS DISEASES

1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia

(2008) L. Senn et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Assessment of the clinical utility of serial  -D-glucan concentrations in patients with persistent neutropenic fever

(2008) M. Ellis et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Developments in the epidemiolgy of invasive fungal infections – implications for the empiric and targeted antifungal therapy

(2008) H. Hof   MYCOSES